Hepatitis B and C are serious health issues affecting millions of people worldwide. According to the World Health Organization (WHO), around 296 million people had chronic hepatitis B in 2019, and about 58 million had chronic hepatitis C in 2020. These infections not only harm the liver but also increase the risk of liver cancer and other serious conditions. This article explains what hepatitis is, the different types of hepatitis viruses, and how hepatitis B and C are linked to cancer. Understanding these viruses and taking preventive steps can help you protect your health and reduce the risk of serious complications.
Hepatitis is inflammation of the liver. Inflammation is swelling that happens when tissues of the body are injured or infected. This swelling and damage can affect how well your liver functions.
Hepatitis can be an acute (short-term) infection or a chronic (long-term) infection. Some types of hepatitis cause only acute infections. Other types can cause both acute and chronic infections of the liver, usually caused by a viral infection.
There are six types of hepatitis viruses: A, B, C, D, E, and G. Among these, hepatitis B and C are particularly concerning due to their strong association with cancer.
Hepatitis B is a virus that targets the liver, leading to inflammation and potential long-term damage. It’s highly contagious and can be either acute (short-term) or chronic (long-term).
Symptoms can vary from mild to severe and may include:
Most Hepatitis B infections clear up on their own, hence follow-ups are recommended. In case of chronic infection, treatment is diagnosed through blood tests. Treatments include antiviral medications that help reduce the virus’s activity and prevent liver damage. In some cases, liver transplantation may be necessary for severe liver damage.
Hepatitis C is a liver infection caused by the hepatitis C virus. It’s known for its tendency to remain asymptomatic in its early stages, often leading to chronic liver disease.
Most people with hepatitis C don’t have symptoms at first. When symptoms do appear, they may include:
Diagnosis involves blood tests to detect the presence of the virus. Modern antiviral medications can cure most cases of hepatitis C, significantly reducing the risk of severe liver disease.
Hepatitis B and C spread through:
Hepatitis B (HBV) and Hepatitis C (HCV) are viral infections that primarily affect the liver, leading to inflammation, fibrosis, and potentially severe liver damage. Both infections significantly increase the risk of developing liver cancer, specifically hepatocellular carcinoma (HCC). Understanding the mechanisms behind this increased risk is crucial for prevention and management.
Co-infection with other viruses such as HIV, lifestyle factors like alcohol abuse, and comorbid conditions such as obesity can worsen liver damage and increase the risk of developing Hepatocellular Carcinoma (HCC).
Hepatocellular Carcinoma is a type of liver cancer that originates in the liver cells (hepatocytes). It often arises in the context of chronic liver disease, including cirrhosis caused by hepatitis infections or other liver conditions. Addressing these risk factors through preventive measures and effective management is crucial in reducing the likelihood of developing HCC.
Chronic HBV and HCV infections can increase the risk of bile duct cancer, although this is less common than liver cancer. The persistent inflammation and scarring in the bile ducts can lead to mutations and cancerous changes.
Studies have shown an association between HCV infection and an increased risk of non-Hodgkin lymphoma. The chronic immune stimulation caused by the virus is believed to contribute to the development of this type of cancer.
Liver cancer often remains asymptomatic in its early stages. As it progresses, you might experience:
Preventing liver cancer involves a combination of vaccination, regular screenings, effective treatments, and healthy lifestyle choices.
Avoiding alcohol, maintaining a healthy weight, and managing conditions like diabetes can help mitigate additional risk factors for liver damage.
If you have hepatitis B or C, don’t worry. Early treatment can help control the infection and prevent serious liver damage and complications.
Hepatitis B and C can cause chronic liver damage and increase cancer risk. By understanding these viruses, taking preventive steps, and seeking early treatment, you can better protect your health and reduce serious complications.
Dr. Shruti Arora, a respected Medical Oncologist and Hemato-oncologist in Mumbai, highlights the importance of regular screenings and tailored treatment plans to manage hepatitis B and C effectively. Addressing these infections early can help prevent severe liver damage and lower cancer risk.
If you are at risk or have been diagnosed with cancer, getting expert care from specialists like Dr. Shruti Arora can be crucial in protecting your health and improving your quality of life.
Preventing liver cancer involves a combination of vaccination, regular screenings, effective treatments, and healthy lifestyle choices.
Dr.Shruti provided exceptional care, expertise, and compassion throughout my treatment, leading to a successful outcome. Her dedication and professionalism made a significant difference in my... ...Read More
I met Dr. Shruti 3 years back at Nanavati hospital when she was assisting Dr. Muzamil Shaik. My mother is being treated at Nanavati under... ...Read More
Former Academic Advisor to Governor of Jharkhand Dr Shruti Arora, is practicing oncologist with a degree in DM Medical Oncology working at Nanavati Max Hospital, ... ...Read More
My personal experience with Dr Shruti ma'am and her team is excellent and our family is extremely grateful to her. A very humble and down ... ...Read More